Announcements Trials
Browse Landscape

Phase

Phase 1/2 2Phase 1 2Phase 3 1

Status

Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2

Conditions

Carcinoma, Non-Small-Cell Lung 85Neoplasm Metastasis 74Colorectal Neoplasms 74Neoplasms 72Leukemia, Myeloid, Acute 62Breast Neoplasms 54Prostatic Neoplasms 47Multiple Myeloma 47Ovarian Neoplasms 42Pancreatic Neoplasms 41Squamous Cell Carcinoma of Head and Neck 38Melanoma 36Recurrence 33Glioblastoma 33Lung Neoplasms 31Myelodysplastic Syndromes 30Triple Negative Breast Neoplasms 29Lymphoma, Non-Hodgkin 29Advanced Solid Tumors 27Endometrial Neoplasms 26Stomach Neoplasms 24Small Cell Lung Carcinoma 24Carcinoma, Renal Cell 24Precursor Cell Lymphoblastic Leukemia-Lymphoma 23Brain Neoplasms 22Carcinoma, Hepatocellular 21Sarcoma 19Lymphoma, B-Cell 19Lymphoma, Large B-Cell, Diffuse 18Esophageal Neoplasms 18

Interventions

sintilimab 1azeliragon 1Radiotherapy 1Pemetrexed 1Immune Checkpoint Inhibitors 1Drug Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × Meningeal Carcinomatosis × 30 days × Clear all
NCT06724926 2026-05-18

Concurrent Azeliragon With Craniospinal Irradiation

NYU Langone Health

Phase 1 Active not recruiting
21 enrolled
CNS

Glioma, Meningeal Carcinomatosis

NCT06431685 2026-05-08

Safety and Efficacy of Whole Brain LDRT+ICI+Intrathecal Chemotherapy in Refractory Meningeal Metastasis of Lung Cancer

Sichuan University

Phase 1 Recruiting
10 enrolled
CNS

Meningeal Carcinomatosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡